lamivudine has been researched along with Germinoblastoma in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (52.94) | 29.6817 |
| 2010's | 8 (47.06) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Chen, LF; Chen, YQ; Hu, HD; Li, H; Ren, H; Zhang, HM | 1 |
| An, J; Choi, J; Chung, YH; Kim, KM; Kim, SO; Kim, SW; Lee, D; Lee, HC; Lee, YS; Lim, YS; Shim, JH; Suh, DJ | 1 |
| Luis, AP; Luo, H; Pan, M; Shuai, P; Xiong, Z; Yu, S; Zhang, Z | 1 |
| Cai, Q; Chen, J; Chen, K; Duan, H; Geng, Q; Hu, L; Huang, H; Jiang, W; Lin, T; Rao, H; Wu, S; Xia, Z; Yao, M | 1 |
| Karsaliakos, P; Mylonakis, E; Ziakas, PD | 1 |
| D'Andrea, M; Dessanti, ML; Miglioresi, L; Morrone, A; Nosotti, L; Paviglianiti, A; Petti, MC; Pimpinelli, F | 1 |
| Chow, WC; Koo, YX; Lim, ST; Tan, DS; Tan, IB; Tao, M | 1 |
| Gong, HY; Liu, ZG; Zhang, HY; Zhang, Z | 1 |
| Guo, CC; Guo, HQ; Huang, JJ; Huang, Y; Li, HR; Lin, TY; Pu, XX; Xie, Y; Zhai, LZ; Zhang, X; Zhu, HL | 1 |
| Deutsch, M; Hatziyanni, E; Manolakopoulos, S; Papadopoulos, N; Vassilopoulos, D | 1 |
| Chen, TY; Huang, WT; Leaw, SJ; Su, WC; Tsao, CJ; Yen, CJ | 1 |
| Del Poggio, P; Jamoletti, C; Zaccanelli, M | 1 |
| Jia, J; Lin, F | 1 |
| Higuchi, T; Kitazume, K; Kura, Y; Mori, H; Okumura, H; Omine, M; Sawada, U; Shimamoto, K; Takai, K; Tomita, N; Yamanaka, S; Yoshiba, S | 1 |
| Cassola, G; Feasi, M; Torresin, A | 1 |
| Dong, MH; Joseph, TA; Saab, S; Tong, MJ | 1 |
| Bao, SP; Guan, ZZ; He, YF; He, YJ; Huang, HQ; Jiang, WQ; Li, YH; Lin, TY; Sun, XF; Wang, FH; Xia, ZJ; Xu, RH; Zhang, L | 1 |
3 review(s) available for lamivudine and Germinoblastoma
| Article | Year |
|---|---|
Prophylactic lamivudine to improve the outcome of HBsAg-positive lymphoma patients during chemotherapy: a systematic review and meta-analysis.
Topics: Antineoplastic Agents; Hepatitis B; Hepatitis B Surface Antigens; Humans; Lamivudine; Lymphoma; Treatment Outcome | 2015 |
Comparison of entecavir and lamivudine in preventing HBV reactivation in lymphoma patients undergoing chemotherapy: a meta-analysis.
Topics: Antineoplastic Agents; Antiviral Agents; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Lymphoma; Treatment Outcome | 2016 |
Effect of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in lymphoma: a meta-analysis of published clinical trials and a decision tree addressing prolonged prophylaxis and maintenance.
Topics: Antiviral Agents; Clinical Trials as Topic; Decision Support Techniques; Hepatitis B; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Lamivudine; Lymphoma; Models, Biological; Reverse Transcriptase Inhibitors; Treatment Outcome | 2009 |
3 trial(s) available for lamivudine and Germinoblastoma
| Article | Year |
|---|---|
[Analysis of the prophylactic effect of nucleosides against reactivation of HBV in HBsAg-positive patients with non-hepatic tumors after chemotherapy].
Topics: Adult; Antineoplastic Agents; Antiviral Agents; Breast Neoplasms; Female; Follow-Up Studies; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Lung Neoplasms; Lymphoma; Male; Middle Aged; Nucleosides; Pyrimidinones; Retrospective Studies; Telbivudine; Thymidine; Virus Activation | 2010 |
Comparison of entecavir and lamivudine in preventing hepatitis B reactivation in lymphoma patients during chemotherapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antiviral Agents; Chemoprevention; China; Female; Guanine; Hepatitis B; Humans; Lamivudine; Lymphoma; Male; Middle Aged; Treatment Outcome; Virus Activation; Young Adult | 2011 |
[Evaluation of prophylactic use of lamivudine in HBV-positive patients with malignant lymphoma undergoing chemotherapy].
Topics: Adult; Aged; Antiviral Agents; Biomarkers; Carrier State; Female; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Liver Failure, Acute; Lymphoma; Male; Middle Aged; Prospective Studies | 2005 |
11 other study(ies) available for lamivudine and Germinoblastoma
| Article | Year |
|---|---|
Comprehensive outcomes of on- and off-antiviral prophylaxis in hepatitis B patients undergoing cancer chemotherapy: A competing risks analysis.
Topics: Adult; Alanine Transaminase; Antineoplastic Agents; Antiviral Agents; DNA, Viral; Female; Guanine; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Lymphoma; Male; Middle Aged; Neoplasms; Retrospective Studies; Risk Assessment; Viral Load; Virus Activation | 2016 |
The Effect of Prophylactic Lamivudine plus Adefovir Therapy Compared with Lamivudine Alone in Preventing Hepatitis B Reactivation in Lymphoma Patients with High Baseline HBV DNA during Chemotherapy.
Topics: Adenine; Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Child; DNA, Viral; Drug Interactions; Female; Hepatitis B virus; Humans; Lamivudine; Lymphoma; Male; Middle Aged; Organophosphonates; Retrospective Studies; Risk; Virus Activation; Young Adult | 2016 |
The controversial role of lamivudine prophylaxis in occult HBV carriers treated with chemo-immune therapy.
Topics: Antiviral Agents; Carrier State; Chemoprevention; Drug-Related Side Effects and Adverse Reactions; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Humans; Lamivudine; Lymphoma; Retrospective Studies | 2009 |
Hepatitis B virus reactivation and role of antiviral prophylaxis in lymphoma patients with past hepatitis B virus infection who are receiving chemoimmunotherapy.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antiviral Agents; Female; Hepatitis B; Hepatitis B virus; Humans; Immunologic Factors; Lamivudine; Lymphoma; Male; Middle Aged; Prevalence; Rituximab; Virus Activation; Virus Latency; Virus Replication | 2010 |
Fatal hepatitis B virus reactivation due to a lamivudine mutant despite undetectable initial viral load.
Topics: Drug Resistance, Viral; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B virus; Humans; Immunosuppression Therapy; Lamivudine; Lymphoma; Male; Middle Aged; Splenic Neoplasms; Viral Load; Virus Activation | 2011 |
Preemptive use of interferon or lamivudine for hepatitis B reactivation in patients with aggressive lymphoma receiving chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cyclophosphamide; Epirubicin; Female; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Interferon-alpha; Lamivudine; Lymphoma; Male; Middle Aged; Prednisone; Preventive Medicine; Retrospective Studies; Reverse Transcriptase Inhibitors; Secondary Prevention; Vincristine; Virus Activation | 2004 |
Preemptive lamivudine in hepatitis B patients undergoing chemotherapy.
Topics: Antineoplastic Agents; Hepatitis B, Chronic; Humans; Lamivudine; Lymphoma; Reverse Transcriptase Inhibitors; Secondary Prevention | 2004 |
[Lamivudine therapy for prevention of chemotherapy-induced reactivation of hepatitis B virus].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Female; Hepatitis B, Chronic; Humans; Lamivudine; Lymphoma; Male; Middle Aged; Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Secondary Prevention; Stomach Neoplasms | 2004 |
Hepatitis B serological evaluation in diagnostic work up of lymphoma.
Topics: Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Lymphoma; Reverse Transcriptase Inhibitors; Virus Activation | 2007 |
Hepatitis B prophylaxis in patients undergoing chemotherapy for lymphoma: a decision analysis model.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cost-Benefit Analysis; Cyclophosphamide; Decision Support Techniques; Doxorubicin; Health Care Costs; Hepatitis B; Humans; Lamivudine; Liver Neoplasms; Lymphoma; Prednisolone; Treatment Outcome; Vincristine | 2007 |
The effectiveness of lamivudine in preventing hepatitis B viral reactivation in rituximab-containing regimen for lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; DNA, Viral; Female; Hepatitis B; Humans; Lamivudine; Lymphoma; Male; Middle Aged; Recurrence; Rituximab; Salvage Therapy; Virus Activation | 2008 |